181 related articles for article (PubMed ID: 3097261)
1. Hydrogen peroxide enhances the activity of monoamine oxidase type-B but not of type-A: a pilot study.
Konradi C; Riederer P; Youdim MB
J Neural Transm Suppl; 1986; 22():61-73. PubMed ID: 3097261
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of monoamine oxidase type A, but not type B, is an effective means of inducing anticonvulsant activity in the kindling model of epilepsy.
Löscher W; Lehmann H; Teschendorf HJ; Traut M; Gross G
J Pharmacol Exp Ther; 1999 Mar; 288(3):984-92. PubMed ID: 10027835
[TBL] [Abstract][Full Text] [Related]
3. Improvement of mouse brain mitochondrial function after deprenyl treatment.
Czerniczyniec A; Bustamante J; Lores-Arnaiz S
Neuroscience; 2007 Jan; 144(2):685-93. PubMed ID: 17084986
[TBL] [Abstract][Full Text] [Related]
4. The imidazoline I2-site ligands BU 224 and 2-BFI inhibit MAO-A and MAO-B activities, hydrogen peroxide production, and lipolysis in rodent and human adipocytes.
Bour S; Iglesias-Osma MC; Marti L; Duro P; Garcia-Barrado MJ; Pastor MF; Prévot D; Visentin V; Valet P; Moratinos J; Carpéné C
Eur J Pharmacol; 2006 Dec; 552(1-3):20-30. PubMed ID: 17056035
[TBL] [Abstract][Full Text] [Related]
5. [Effect of solubilization by methylethylketone of rat liver mitochondrial monoamine oxidase on inhibition by clorgyline and deprenyl of the enzyme activity].
Severina IS; Klimova GI; Nersisian AA
Biokhimiia; 1981 Nov; 46(11):2043-55. PubMed ID: 6797482
[TBL] [Abstract][Full Text] [Related]
6. Modulation of brain mitochondrial function by deprenyl.
Czerniczyniec A; Bustamante J; Lores-Arnaiz S
Neurochem Int; 2006 Feb; 48(3):235-41. PubMed ID: 16289465
[TBL] [Abstract][Full Text] [Related]
7. Effect of lignocaine on monoamine oxidase activity of brain and liver.
Haque SJ; Poddar MK
Methods Find Exp Clin Pharmacol; 1984 Mar; 6(3):119-24. PubMed ID: 6748816
[TBL] [Abstract][Full Text] [Related]
8. Increase of monoamine oxidase-B activity in the brain of scrapie-infected hamsters.
Adjou KT; Dilda P; Aumond P; Gueddari S; Deslys JP; Dormont D; Seman M
Neurochem Int; 2008 Jun; 52(8):1416-21. PubMed ID: 18442871
[TBL] [Abstract][Full Text] [Related]
9. Food constituents attenuate monoamine oxidase activity and peroxide levels in C6 astrocyte cells.
Mazzio EA; Harris N; Soliman KF
Planta Med; 1998 Oct; 64(7):603-6. PubMed ID: 9810264
[TBL] [Abstract][Full Text] [Related]
10. Assessment of MAO-B occupancy in the brain with PET and [11C]-L-deprenyl-D2: a dose-finding study with a novel MAO-B inhibitor, EVT 301.
Hirvonen J; Kailajärvi M; Haltia T; Koskimies S; Någren K; Virsu P; Oikonen V; Sipilä H; Ruokoniemi P; Virtanen K; Scheinin M; Rinne JO
Clin Pharmacol Ther; 2009 May; 85(5):506-12. PubMed ID: 19129751
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of monoamine oxidase A and B activities by imidazol(ine)/guanidine drugs, nature of the interaction and distinction from I2-imidazoline receptors in rat liver.
Ozaita A; Olmos G; Boronat MA; Lizcano JM; Unzeta M; García-Sevilla JA
Br J Pharmacol; 1997 Jul; 121(5):901-12. PubMed ID: 9222546
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of monoamine oxidase B in the brains of smokers.
Fowler JS; Volkow ND; Wang GJ; Pappas N; Logan J; MacGregor R; Alexoff D; Shea C; Schlyer D; Wolf AP; Warner D; Zezulkova I; Cilento R
Nature; 1996 Feb; 379(6567):733-6. PubMed ID: 8602220
[TBL] [Abstract][Full Text] [Related]
13. Developmental aspects of the monoamine-degrading enzyme monoamine oxidase.
Strolin Benedetti M; Dostert P; Tipton KF
Dev Pharmacol Ther; 1992; 18(3-4):191-200. PubMed ID: 1306808
[TBL] [Abstract][Full Text] [Related]
14. Pharmacology of MAO B inhibitors: mode of action of (-)deprenyl in Parkinson's disease.
Youdim MB
J Neural Transm Suppl; 1986; 22():91-105. PubMed ID: 3097263
[TBL] [Abstract][Full Text] [Related]
15. [The effect of emotional stress and corticosterone on the activity of monoaminoxidase in the rat brain].
Popova NK; Voĭtenko NN; Maslova LN
Vopr Med Khim; 1989; 35(4):114-9. PubMed ID: 2815668
[TBL] [Abstract][Full Text] [Related]
16. Induction of monoamine oxidase B by 17 beta-estradiol in the hamster kidney preceding carcinogenesis.
Sarabia SF; Liehr JG
Arch Biochem Biophys; 1998 Jul; 355(2):249-53. PubMed ID: 9675034
[TBL] [Abstract][Full Text] [Related]
17. Species-dependent differences in monoamine oxidase A and B-catalyzed oxidation of various C4 substituted 1-methyl-4-phenyl-1,2,3, 6-tetrahydropyridinyl derivatives.
Inoue H; Castagnoli K; Van Der Schyf C; Mabic S; Igarashi K; Castagnoli N
J Pharmacol Exp Ther; 1999 Nov; 291(2):856-64. PubMed ID: 10525109
[TBL] [Abstract][Full Text] [Related]
18. High-throughput screening for monoamine oxidase-A and monoamine oxidase-B inhibitors using one-step fluorescence assay.
Guang HM; Du GH
Acta Pharmacol Sin; 2006 Jun; 27(6):760-6. PubMed ID: 16723097
[TBL] [Abstract][Full Text] [Related]
19. Localization of MAO-A and MAO-B in human brain: a step in understanding the therapeutic action of L-deprenyl.
Riederer P; Konradi C; Schay V; Kienzl E; Birkmayer G; Danielczyk W; Sofic E; Youdim MB
Adv Neurol; 1987; 45():111-8. PubMed ID: 3030067
[TBL] [Abstract][Full Text] [Related]
20. The metabolism of tyramine by monoamine oxidase A/B causes oxidative damage to mitochondrial DNA.
Hauptmann N; Grimsby J; Shih JC; Cadenas E
Arch Biochem Biophys; 1996 Nov; 335(2):295-304. PubMed ID: 8914926
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
